← Yangiliklar markaziga qaytish
Sog‘liq
FDA Launches the Global Reliance Disclosure Program to Expand Patient Access to Medicines Worldwide
Manba: U.S. Food and Drug Administration (FDA)
E’lon qilingan:
Tarjima qilinmagan — asl tilda ko‘rsatilgan (ingliz tili).
Manba bergan mazmun — U.S. Food and Drug Administration (FDA)
FDA today announced the Global Reliance Disclosure Program (GRDP), a landmark initiative that will fundamentally transform how the FDA's regulatory drug and biologic approval decisions are leveraged by health authorities around the world.
Bu sahifada nashriyot bildirgan ma’lumot keltirilgan. MYITEDU bu da’volarni mustaqil tekshirmagan.
Asl maqolani o‘qish — U.S. Food and Drug Administration (FDA) ↗
Manba ko‘rsatilishi: Source: U.S. Food and Drug Administration (fda.gov)
Ulashish
Instagram saytlardan havola ulashishni qo‘llab-quvvatlamaydi. Kartani yuklab oling, Instagram ilovasida joylang va izohni qo‘ying.
Tuzatish haqida xabar berish
Materialdagi, tarjimadagi, sanadagi yoki manba ko‘rsatilishidagi xato haqida xabar bering. Aloqa ma’lumotlaringiz maxfiy saqlanadi va faqat javob berish uchun ishlatiladi.